Literature DB >> 16158068

Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin.

Pascale Gluais1, Michel Lonchampt, Jason D Morrow, Paul M Vanhoutte, Michel Feletou.   

Abstract

In the spontaneously hypertensive rat (SHR) and aging Wistar-Kyoto rats (WKY), acetylcholine releases an endothelium-derived contracting factor (EDCF) produced by endothelial cyclooxygenase-1, which stimulates thromboxane A2 receptors (TP receptors) on vascular smooth muscle. The purpose of the present study was to identify this EDCF by measuring changes in isometric tension and the release of various prostaglandins by acetylcholine. In isolated aortic rings of SHR, U 46619, prostaglandin (PG) H2, PGF2alpha, PGE2, PGD2, prostacyclin (PGI2) and 8-isoprostane, all activate TP receptors of the vascular smooth muscle to produce a contraction (U 46619>>8-isoprostane=PGF2alpha=PGH2>PGE2=PGD2>PGI2). The contractions produced by PGH2 and PGI2 were fast and transient, mimicking endothelium-dependent contractions. PGI2 did not relax isolated aortic rings of WKY and SHR. Acetylcholine evoked the endothelium-dependent release of thromboxane A2, PGF2alpha, PGE2, PGI2 and most likely PGH2 (PGI2>>PGF2alpha>or=PGE2>TXA2>8-isoprostane, PGD2). Dazoxiben abolished the production of thromboxane A2, but did not influence the endothelium-dependent contractions to acetylcholine. The release of PGI2 was significantly larger in the aorta of SHR than in WKY, and the former was more sensitive to the contractile effect of PGI2 than the latter. The inhibition of PGI-synthase was associated with an increase in PGH2 spillover and the enhancement of acetylcholine-induced endothelium-dependent contractions. Thus, in the aorta of SHR and aging WKY, the endothelium-dependent contractions elicited by acetylcholine most likely involve the release of PGI2 with a concomitant contribution of PGH2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16158068      PMCID: PMC1751221          DOI: 10.1038/sj.bjp.0706390

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  Stimulation of human foreskin fibroblast adenosine 3':5'-cyclic monophosphate levels by prostacyclin (prostaglandin I2).

Authors:  R R Gorman; R D Hamilton; N K Hopkins
Journal:  J Biol Chem       Date:  1979-03-10       Impact factor: 5.157

2.  Endothelial cell activation by endotoxin involves superoxide/NO-mediated nitration of prostacyclin synthase and thromboxane receptor stimulation.

Authors:  Markus Bachschmid; Svenja Thurau; Ming-Hui Zou; Volker Ullrich
Journal:  FASEB J       Date:  2003-03-28       Impact factor: 5.191

3.  Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats.

Authors:  Javier Blanco-Rivero; Victoria Cachofeiro; Vicente Lahera; Rosa Aras-Lopez; Iván Márquez-Rodas; Mercedes Salaices; Fabiano E Xavier; Mercedes Ferrer; Gloria Balfagón
Journal:  Hypertension       Date:  2005-06-13       Impact factor: 10.190

Review 4.  Prostaglandin E synthase.

Authors:  Makoto Murakami; Yoshihito Nakatani; Toshihiro Tanioka; Ichiro Kudo
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-08       Impact factor: 3.072

5.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

6.  The effect of prostacyclin on the human umbilical artery.

Authors:  K Pomerantz; A Sintetos; P Ramwell
Journal:  Prostaglandins       Date:  1978-06

7.  Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.

Authors:  M Hamberg; J Svensson; T Wakabayashi; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

8.  A diffusible substance(s) mediates endothelium-dependent contractions in the aorta of SHR.

Authors:  Di Yang; Michel Félétou; Nigel Levens; Ji Nan Zhang; Paul M Vanhoutte
Journal:  Hypertension       Date:  2003-01       Impact factor: 10.190

9.  Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid.

Authors:  R R Gorman; G L Bundy; D C Peterson; F F Sun; O V Miller; F A Fitzpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

10.  Nitric oxide and inactivation of the endothelium-dependent contracting factor released by acetylcholine in spontaneously hypertensive rat.

Authors:  Di Yang; Pascale Gluais; Ji Nan Zhang; Paul M Vanhoutte; Michel Félétou
Journal:  J Cardiovasc Pharmacol       Date:  2004-06       Impact factor: 3.105

View more
  64 in total

Review 1.  Vasoconstrictor prostanoids.

Authors:  Michel Félétou; Yu Huang; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-03-24       Impact factor: 3.657

2.  Oxidative stress-dependent cyclooxygenase-2-derived prostaglandin f(2α) impairs endothelial function in renovascular hypertensive rats.

Authors:  Xiao Yu Tian; Wing Tak Wong; Fung Ping Leung; Yang Zhang; Yi-Xiang Wang; Hung Kay Lee; Chi Fai Ng; Zhen Yu Chen; Xiaoqiang Yao; Chak Leung Au; Chi Wai Lau; Paul M Vanhoutte; John P Cooke; Yu Huang
Journal:  Antioxid Redox Signal       Date:  2011-12-02       Impact factor: 8.401

3.  Chronic in vivo or acute in vitro resveratrol attenuates endothelium-dependent cyclooxygenase-mediated contractile signaling in hypertensive rat carotid artery.

Authors:  Steven G Denniss; Rebecca J Ford; Christopher S Smith; Andrew J Jeffery; James W E Rush
Journal:  J Appl Physiol (1985)       Date:  2016-02-25

4.  Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Styliani Goulopoulou; Safia Ogbi; Takayuki Matsumoto; R Clinton Webb
Journal:  Pharmacol Res       Date:  2016-09-14       Impact factor: 7.658

Review 5.  Endothelial dysfunction: a strategic target in the treatment of hypertension?

Authors:  Eva H C Tang; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-02-02       Impact factor: 3.657

Review 6.  Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.

Authors:  Takayuki Matsumoto; Styliani Goulopoulou; Kumiko Taguchi; Rita C Tostes; Tsuneo Kobayashi
Journal:  Br J Pharmacol       Date:  2015-07-08       Impact factor: 8.739

7.  Oxygen-derived free radicals mediate endothelium-dependent contractions in femoral arteries of rats with streptozotocin-induced diabetes.

Authors:  Y Shi; K-F So; R Y K Man; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2007-09-03       Impact factor: 8.739

8.  Decreased contraction induced by endothelium-derived contracting factor in prolonged treatment of rat renal artery with endoplasmic reticulum stress inducer.

Authors:  Makoto Ando; Takayuki Matsumoto; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-04       Impact factor: 3.000

9.  Impaired UTP-induced relaxation in the carotid arteries of spontaneously hypertensive rats.

Authors:  Takayuki Matsumoto; Mihoka Kojima; Keisuke Takayanagi; Tomoki Katome; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Purinergic Signal       Date:  2020-08-29       Impact factor: 3.765

Review 10.  Endothelium-dependent contractions: when a good guy turns bad!

Authors:  Paul M Vanhoutte; Eva H C Tang
Journal:  J Physiol       Date:  2008-09-25       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.